Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Perrigo Company (PRGO) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 12,139,137
  • Shares Outstanding, K 143,370
  • Annual Sales, $ 2,770 M
  • Annual Income, $ 6 M
  • 36-Month Beta 0.73
  • Price/Sales 2.15
  • Price/Book 1.40

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.84 +17.86%
on 01/24/17
85.27 -0.70%
on 02/15/17
+9.61 (+12.80%)
since 01/20/17
3-Month
71.84 +17.86%
on 01/24/17
89.81 -5.72%
on 11/25/16
-4.64 (-5.20%)
since 11/21/16
52-Week
71.84 +17.86%
on 01/24/17
140.65 -39.80%
on 03/14/16
-44.67 (-34.54%)
since 02/19/16

Most Recent Stories

More News
Perrigo Company plc Announces Quarterly Dividend

Perrigo Company plc (NYSE, TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.16 per share, payable on March 21, 2017 to shareholders of record on March 3, 2017....

PRGO : 84.67 (+0.24%)
Perrigo Company (PRGO) Q4 Earnings: Disappointment in Store?

Perrigo Company plc (PRGO) is expected to report fourth-quarter 2016 results this month. Perrigo has a mixed track record as the company beat expectations in two of the last four quarters and missed the...

BMRN : 90.24 (+0.41%)
ACOR : 25.30 (unch)
AMAG : 23.90 (-1.04%)
PRGO : 84.67 (+0.24%)
Perrigo's (PRGO) Generic Version of Topicort Okayed by FDA

Perrigo Company plc (PRGO) recently announced that the FDA has approved its first-to-file AB rated generic version of Taro Pharmaceuticals's Topicort spray, 0.25% indicated for the treatment of plaque...

ENZ : 6.71 (-1.90%)
TARO : 115.21 (-1.29%)
PRGO : 84.67 (+0.24%)
BIIB : 286.90 (-0.71%)
Perrigo Announces FDA Approval Of Its First-To-File AB Rated Generic Version Of Topicort® Spray, 0.25%

Perrigo Company plc (NYSE; TASE: PRGO) today announced it has received U.S. Food and Drug Administration approval for its first-to-file Abbreviated New Drug Application referencing Taro Pharmaceuticals...

PRGO : 84.67 (+0.24%)
Is Perrigo Company (PRGO) a Great Stock for Value Investors?

Let's delve into the value metrics of Perrigo Company (PRGO) and determine whether it is a good value investment right now.

PRGO : 84.67 (+0.24%)
Perrigo Updates Segment Reporting Structure

Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has changed its reporting segments to better align with the Company's organizational structure. Beginning with the fourth quarter of calendar...

PRGO : 84.67 (+0.24%)
TLC Therapeutics, LLC Announces Multi-Product Licensing and Manufacturing Agreement with Rosemont Pharmaceuticals

TLC Therapeutics, LLC, a Baltimore-based pharmaceutical company, announces the execution of an exclusive, multi-product licensing and manufacturing agreement with Rosemont Pharmaceuticals, an UK-based...

PRGO : 84.67 (+0.24%)
Custopharm Acquires Two ANDA Pharmaceutical Products From Perrigo

Custopharm, Inc., a U.S. leader in generic injectable products, announced today that it has acquired two paragraph IV abbreviated new drug application (ANDA) products from Perrigo Company plc.

PRGO : 84.67 (+0.24%)
Perrigo to Present at the J.P. Morgan Global Healthcare Conference

Perrigo Company plc (NYSE: PRGO; TASE) today announced that CEO John T. Hendrickson will present at the J.P. Morgan Global Healthcare Conference at 11:00 AM EST on Tuesday, January 10, 2017 at the Westin...

JPM : 91.01 (+0.86%)
PRGO : 84.67 (+0.24%)
Research and Markets - World Clinical Nutrition Products (Infant, Parenteral and Enteral Foods) Market 2016-2022 Featuring Hospira, Nestle, and Perrigo

Research and Markets has announced the addition of the "The World Market for Clinical Nutrition Products (Infant, Parenteral and Enteral Foods), 7th Edition" report to their offering.

PRGO : 84.67 (+0.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is in highly overbought territory. Beware of a trend reversal.

See More

Business Summary

Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United...

See More

Support & Resistance

2nd Resistance Point 85.72
1st Resistance Point 85.19
Last Price 84.67
1st Support Level 83.86
2nd Support Level 83.06

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.